课题基金 / 基金详情

Folding, Mis-Folding and Aggregation of Small Proteins

Folding, Mis-Folding and Aggregation of Small Proteins
小蛋白质的折叠、错误折叠和聚集
批准号:
7737943
负责人:
ULRICH H.E. HANSMANN
金额:
$21.3万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-06-01 至 2013-06-30

项目摘要

项目成果

ULRICH H.E. HANSMANN的其他基金

相关文献

中文摘要
翻译
描述(由申请人提供):合理的药物设计或淀粉样蛋白疾病的病理只是两个问题,其解决方案需要详细了解蛋白质的化学组成和结构(和功能)之间的关系。本项目描述了通过计算机模拟来探索这种关系的尝试。目的是了解蛋白质的折叠和相互作用,仅从蛋白质内原子之间的物理力,以及蛋白质与周围环境之间的物理力。PI扩展了以前的工作,并依赖于他的团队开发的算法,旨在导出描述细胞中蛋白质折叠,聚集和相互作用的基本过程的模型。例如,PI将通过计算机模拟研究两种蛋白质(64个残基的糜蛋白酶抑制剂2和93个残基的蛋白质TOP 7)折叠成其特定形状的机制。这本身就是一个大胆的计算任务,需要进一步的算法进步和大规模并行软件的实现。模拟这些分子,PI将不会推动计算机模拟超出其目前的限制,并建立规则,描述折叠在小蛋白质。了解这些规则将为更有效的药物设计方法铺平道路。在第二条研究路线中,PI超越了单一蛋白质,并研究了多个A链之间的相互作用及其随后的寡聚化。他将研究哪些因素有利于寡聚物物种的单体状态,以及点突变和金属离子对寡聚物稳定性的影响。由于A聚集体与阿尔茨海默病的神经病理学有关,这项研究将有助于对这种疾病的生物起源的理解。 公共卫生相关性:小分子蛋白质的折叠、错误折叠和聚集项目叙述计算机模拟被提出来研究蛋白质折叠成其生物活性形式的过程,以及这些分子错误折叠和随后聚集的条件。这将有助于了解与错误折叠和聚集相关的疾病的生物起源,并可能导致更有效的药物设计方法。
英文摘要
DESCRIPTION (provided by applicant): Rational drug design or the pathology of amyloid diseases are only two problems whose solution requires a detailed understanding of the relation between chemical composition and structure (and function) of proteins. The present project describes attempts to explore this relationship through computer simulations. The goal is to understand the folding and interaction of proteins solely from the physical forces between the atoms within a protein, and between the protein and the surrounding environment. Extending previous work and relying on algorithms developed in his group, the PI aims at deriving models that describe the fundamental processes of protein folding, aggregation and interaction in a cell. As an example, the PI will study in silico the mechanism by that two proteins, the 64- residue Chymotrypsin Inhibitor 2 and the 93-residue protein TOP7, fold into their specific shape. This is in itself a daring computational task that will require further algorithmic advances and implementation in massively parallel software. Simulating these molecules the PI will not push computer simulations beyond its present limits, and establish rules that describe folding in small proteins. Knowledge of such rules will pave the way to more efficient ways of drug design. In a second line of research the PI goes beyond single proteins and studies the interaction between multiple A chains and their subsequent oligomerization. He will investigate what factors favor oligomeric species over monomeric states, and the effect of point mutations and metal ions on the stability of the oligomers. As A aggregates are connected with the neuropathology of Alzheimer's disease this study will contribute to the developing understanding of the biogenesis of this disease. PUBLIC HEALTH RELEVANCE: Folding, Misfolding and Aggregation of Small Proteins Project Narrative Computer simulations are proposed to study the process by that proteins fold into their biologically active form, and the conditions under that these molecules misfold and subsequently aggregate. This will contribute to the developing understanding of the biogenesis of diseases related to misfolding and aggregation, and could lead to more efficient ways of drug design.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Structural Transitions in Proteins and Protein Assemblies
  • 批准号:
    10001539
  • 项目类别:
  • 资助金额:
    $29.61万
  • 财政年份:
    2017
  • 负责人:
    ULRICH H.E. HANSMANN
  • 依托单位:
Folding, Mis-Folding and Aggregation of Small Proteins
  • 批准号:
    8340518
  • 项目类别:
  • 资助金额:
    $18.33万
  • 财政年份:
    2003
  • 负责人:
    ULRICH H.E. HANSMANN
  • 依托单位:
Folding and Structural Transitions in Small Proteins
  • 批准号:
    7069015
  • 项目类别:
  • 资助金额:
    $14.63万
  • 财政年份:
    2003
  • 负责人:
    ULRICH H.E. HANSMANN
  • 依托单位:
Folding and Structural Transitions in Small Proteins
  • 批准号:
    6747723
  • 项目类别:
  • 资助金额:
    $15.09万
  • 财政年份:
    2003
  • 负责人:
    ULRICH H.E. HANSMANN
  • 依托单位: